Haleon plc (NYSE:HLN) Stock Position Lessened by JTC Employer Solutions Trustee Ltd

JTC Employer Solutions Trustee Ltd decreased its holdings in Haleon plc (NYSE:HLN - Free Report) by 85.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 376,834 shares of the company's stock after selling 2,168,878 shares during the quarter. JTC Employer Solutions Trustee Ltd's holdings in Haleon were worth $3,216,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Hexagon Capital Partners LLC boosted its stake in Haleon by 107.3% during the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company's stock valued at $35,000 after buying an additional 2,193 shares in the last quarter. Pinnacle Bancorp Inc. boosted its stake in Haleon by 853.4% during the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company's stock valued at $39,000 after buying an additional 4,267 shares in the last quarter. Allspring Global Investments Holdings LLC bought a new position in Haleon during the first quarter valued at about $43,000. Tower Research Capital LLC TRC boosted its stake in Haleon by 146.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company's stock valued at $44,000 after buying an additional 3,211 shares in the last quarter. Finally, SRS Capital Advisors Inc. boosted its stake in Haleon by 456.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 5,458 shares of the company's stock valued at $45,000 after buying an additional 4,477 shares in the last quarter. Institutional investors own 6.67% of the company's stock.

Haleon Stock Up 1.5 %

Shares of HLN traded up $0.12 during midday trading on Wednesday, reaching $8.46. 1,761,769 shares of the stock were exchanged, compared to its average volume of 5,338,670. Haleon plc has a 12-month low of $7.70 and a 12-month high of $8.96. The firm has a 50 day simple moving average of $8.41 and a 200-day simple moving average of $8.35. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The company has a market cap of $38.61 billion, a price-to-earnings ratio of 28.18, a P/E/G ratio of 2.19 and a beta of 0.25.

Haleon (NYSE:HLN - Get Free Report) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.12 earnings per share for the quarter, topping analysts' consensus estimates of $0.11 by $0.01. The company had revenue of $3.70 billion during the quarter, compared to the consensus estimate of $3.71 billion. Haleon had a return on equity of 13.17% and a net margin of 9.68%. Research analysts forecast that Haleon plc will post 0.46 EPS for the current year.

Wall Street Analysts Forecast Growth

HLN has been the subject of several research reports. Berenberg Bank initiated coverage on Haleon in a research note on Wednesday, June 5th. They set a "buy" rating for the company. Argus reiterated a "buy" rating on shares of Haleon in a research report on Tuesday, March 26th. Finally, HSBC initiated coverage on Haleon in a research report on Wednesday, April 17th. They issued a "buy" rating for the company. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, Haleon has an average rating of "Moderate Buy".

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.